Cargando…
Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma
BACKGROUND: Biomarker research in head and neck squamous cell carcinoma (HNSCC) is constantly revealing promising findings. An enhancer of polycomb homolog 1 (EPC1) was found to play a procancer role in nasopharyngeal carcinoma (NPC), but its role in HNSCC with strong heterogeneity is still unclear....
Autores principales: | Dai, Yongmei, Chen, Wenhan, Huang, Junpeng, Zheng, Lijing, Lin, Qing, Cui, Tongjian, Huang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507713/ https://www.ncbi.nlm.nih.gov/pubmed/36158885 http://dx.doi.org/10.1155/2022/1074412 |
Ejemplares similares
-
FCGR2A Could Function as a Prognostic Marker and Correlate with Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Dai, Yongmei, et al.
Publicado: (2021) -
Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma
por: Shi, Yunbin, et al.
Publicado: (2023) -
A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Mai, Zizhao, et al.
Publicado: (2022) -
MeCP2 mediated dysfunction in senescent EPCs
por: Wang, Chunli, et al.
Publicado: (2017) -
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
por: Yao, Yao, et al.
Publicado: (2020)